Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
Tóm tắt
Từ khóa
Tài liệu tham khảo
2008, The global burden of disease: 2004 update
KL O'Brien, 2009, The global burden of disease due to <italic>Streptococcus pneumoniae</italic> in children less than 5 years of age., Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6
WP Hausdorff, 2000, Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I., Clin Infect Dis, 30, 100, 10.1086/313608
T Cherian, 2007, WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26–27 October 2006, Geneva., Vaccine, 25, 6557, 10.1016/j.vaccine.2007.06.044
2009, Global literature review of <italic>Haemophilus influenzae</italic> type b and <italic>Streptococcus pneumoniae</italic> invasive disease among children less than five years of age 1980–2005
R DerSimonian, 1986, Meta-analysis in clinical trials., Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2
World Population Prospects: The 2004 Revision Analytical Report.
JL Fleiss, 1986, The design and analysis of clinical experiments
CG Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine., N Engl J Med, 348, 1737, 10.1056/NEJMoa022823
CG Whitney, 2006, Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study., Lancet, 368, 1495, 10.1016/S0140-6736(06)69637-2
J Eskola, 1998, Clinical evaluation of new pneumococcal vaccines: the Finnish approach., Dev Biol Stand, 95, 85
IH Park, 2007, Discovery of a new capsular serotype (6C) within serogroup 6 of <italic>Streptococcus pneumoniae</italic>., J Clin Microbiol, 45, 1225, 10.1128/JCM.02199-06
IH Park, 2007, Genetic basis for the new pneumococcal serotype, 6C., Infect Immun, 75, 4482, 10.1128/IAI.00510-07
R Dagan, 2009, Serotype replacement in perspective., Vaccine, 27, C22, 10.1016/j.vaccine.2009.06.004
DGE Constenla, 2009, The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean: a review of the evidence and a preliminary economic analysis
S Yaro, 2006, Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso., Clin Infect Dis, 43, 693, 10.1086/506940
A Fenoll, 2009, Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007., J Clin Microbiol, 47, 1012, 10.1128/JCM.01454-08
R Lagos, 2008, Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994–2007., J Infect Dis, 198, 1809, 10.1086/593334
MD Knoll, 2009, Standardizing surveillance of pneumococcal disease., Clin Infect Dis, 48, S37, 10.1086/596480
OS Levine, 2009, Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries., Clin Infect Dis, 48, S33, 10.1086/596479
GD Rodenburg, 2010, Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands., Emerg Infect Dis, 16, 816, 10.3201/eid1605.091223
M Imöhl, 2010, Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992–2008)., Int J Microbiol, 2010, 874189, 10.1155/2010/874189
TN Winther, 2009, Invasive pneumococcal disease in Danish children, 1996–2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine., Acta Paediatr, 98, 328, 10.1111/j.1651-2227.2008.01080.x
2003, Pneumococcal vaccines., Wkly Epidemiol Rec, 78, 97
2001, General Assembly, 56th session. Road map towards the implementation of the United Nations millennium declaration: report of the Secretary-General New York
2008, Pneumococcal Regional Serotype Distribution for Pneumococcal TPP.